The House Institute participated in an industry-sponsored trial for an experimental medication that treats severe tinnitus, or ringing in the ears. The trial required that we recruit patients with severe tinnitus in one ear that had been present no longer than six months.
The medication was injected through the eardrum (tympanic membrane), then absorbed into the inner ear. This was a double-blinded, placebo-controlled study, meaning neither the patient nor the doctor knew if they were getting the real medication or a placebo. The goal of this trial was to better understand how effective this treatment could be in alleviating tinnitus for patients. Data from this study is still being collected and analyzed.